Congenital disorders of glycosylation: A multi-genetic disease family with multiple subcellular locations

Jaeken, Jaak

doi:10.34763/jmotherandchild.20202402si.2005.000004

Abstract

This review discusses a selection of congenital disorders of glycosylation that show peculiar features, such as an unusual presentation, different phenotypes, a novel biochemical/genetic mechanism, a relatively high frequency or a relatively efficient treatment.

References

Ferreira CR, Altassan R, Marques-Da-Silva D, Francisco R, Jaeken J, Morava E. Recognizable phenotypes in CDG. J Inherit Metab Dis. 2018;41(3):541–53. doi: 10.1007/s10545-018-0156-5
Open DOI Search in Google Scholar Back to article
Francisco R, Marques-da-Silva D, Brasil S, Pascoal C, Dos Reis Ferreira V, Morava E, et al. The challenge of CDG diagnosis. Mol Genet Metab. 2019;126(1):1–5. doi: 10.1016/j.ymg-me.2018.11.003
Open DOI Search in Google Scholar Back to article
Jaeken J, Péanne R. What is new in CDG? J Inherit Metab Dis. 2017;40(4):569–86. doi: 10.1007/s10545-017-0050-6. Erratum in: J Inherit Metab Dis. 2017;40(4):621–5. doi: 10.1007/s10545-017-0068-9
Open DOI Search in Google Scholar Back to article
Péanne R, de Lonlay P, Foulquier F, Kornak U, Lefeber DJ, Morava E, et al. Congenital disorders of glycosylation (CDG): Quo vadis? Eur J Med Genet. 2018;61(11):643–63. doi: 10.1016/j.ejmg.2017.10.012
Open DOI Search in Google Scholar Back to article
Grünewald S. The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia). Biochim Biophys Acta. 2009;1792(9):827– 34. doi: 10.1016/j.bbadis.2009.01.003
Open DOI Search in Google Scholar Back to article
Cabezas OR, Flanagan SE, Stanescu H, García-Martínez E, Caswell R, Lango-Allen H, et al. Polycystic kidney disease with hyperinsulinemic hypoglycemia caused by a promoter mutation in phosphomannomutase 2. J Am Soc Nephrol. 2017;28(8):2529– 39. doi: 10.1681/ASN.2016121312
Open DOI Search in Google Scholar Back to article
Verheijen J, Tahata S, Kozicz T, Witters P, Morava E. Therapeutic approaches in congenital disorders of glycosylation (CDG) involving N-linked glycosylation: an update. Genet Med. 2020;22(2):268–79. doi: 10.1038/s41436-019-0647-2
Open DOI Search in Google Scholar Back to article
Martínez-Monseny AF, Bolasell M, Callejón-Póo L, Cuadras D, Freniche V, Itzep DC, et al. AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG). Ann Neurol. 2019;85(5):740–51. doi: 10.1002/ana.25457
Open DOI Search in Google Scholar Back to article
Jaeken J, Lefeber D, Matthijs G. Clinical utility gene card for: Phosphomannose isomerase deficiency. Eur J Hum Genet. 2014;22(9):1153. doi: 10.1038/ejhg.2014.29
Open DOI Search in Google Scholar Back to article
Diaz J, Kane TD, Leon E. Evidence of GMPPA founder mutation in indigenous Guatemalan population associated with alacrima, achalasia, and mental retardation syndrome. Am J Med Genet A. 2020;182(3):425–30. doi: 10.1002/ajmg.a.61476
Open DOI Search in Google Scholar Back to article
Astrea G, Romano A, Angelini C, Antozzi CG, Barresi R, Battini R, et al. Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study. Orphanet J Rare Dis. 2018;13(1):170. doi: 10.1186/s13023-018-0863-x
Open DOI Search in Google Scholar Back to article
Koch J, Mayr JA, Alhaddad B, Rauscher C, Bierau J, Kovacs-Nagy R, et al. CAD mutations and uridine-responsive epileptic encephalopathy. Brain. 2017;140(2):279–86. doi: 10.1093/brain/aww300
Open DOI Search in Google Scholar Back to article
Radenkovic S, Bird MJ, Emmerzaal TL, Wong SY, Felgueira C, Stiers KM, et al. The metabolic map into the pathomechanism and treatment of PGM1-CDG. Am J Hum Genet. 2019;104(5):835– 46. doi: 10.1016/j.ajhg.2019.03.003
Open DOI Search in Google Scholar Back to article
Jaeken J, Lefeber DJ, Matthijs G. Clinical utility gene card for: PGM3 defective congenital disorder of glycosylation. Eur J Hum Genet. 2019;27(11):1757–60. doi: 10.1038/s41431-019-0453-y
Open DOI Search in Google Scholar Back to article
Schröder KC, Duman D, Tekin M, Schanze D, Sukalo M, Meester J, et al. Adams-Oliver syndrome caused by mutations of the EOGT gene. Am J Med Genet A. 2019;179(11):2246–51. doi: 10.1002/ajmg.a.61313
Open DOI Search in Google Scholar Back to article
Pravata VM, Muha V, Gundogdu M, Ferenbach AT, Kakade PS, Vandadi V, et al. Catalytic deficiency of O-GlcNAc transferase leads to X-linked intellectual disability. Proc Natl Acad Sci USA. 2019;116(30):14961–70. doi: 10.1073/pnas.1900065116
Open DOI Search in Google Scholar Back to article
Lam BL, Züchner SL, Dallman J, Wen R, Alfonso EC, Vance JM, et al. Mutation K42E in dehydrodolichol diphosphate synthase (DHDDS) causes recessive retinitis pigmentosa. Adv Exp Med Biol. 2014;801:165–70. doi: 10.1007/978-1-4614-3209-8_21
Open DOI Search in Google Scholar Back to article
Hamdan FF, Myers CT, Cossette P, Lemay P, Spiegelman D, Laporte AD, et al. High rate of recurrent De Novo mutations in developmental and epileptic encephalopathies. Am J Hum Genet. 2017;101(5):664–85. doi: 10.1016/j.ajhg.2017.09.008
Open DOI Search in Google Scholar Back to article
Ng BG, Shiryaev SA, Rymen D, Eklund EA, Raymond K, Kircher M, et al. ALG1-CDG: clinical and molecular characterization of 39 unreported patients. Hum Mutat. 2016;37(7):653–60. doi: 10.1002/humu.22983
Open DOI Search in Google Scholar Back to article
Morava E, Tiemes V, Thiel C, Seta N, de Lonlay P, de Klerk H, et al. ALG6-CDG: a recognizable phenotype with epilepsy, proximal muscle weakness, ataxia and behavioral and limb anomalies. J Inherit Metab Dis. 2016;39(5):713–23. doi: 10.1007/s10545-016-9945-x. Erratum in: J Inherit Metab Dis. 2016 Sep;39(5):759. doi: 10.1007/s10545-016-9967-4
Open DOI Search in Google Scholar Back to article
Davis K, Webster D, Smith C, Jackson S, Sinasac D, Seargeant L, et al. ALG9-CDG: new clinical case and review of the literature. Mol Genet Metab Rep. 2017;13:55–63. doi: 10.1016/j. ymgmr.2017.08.004
Open DOI Search in Google Scholar Back to article
Besse W, Chang AR, Luo JZ, Triffo WJ, Moore BS, Gulati A, et al. ALG9 mutation carriers develop kidney and liver cysts. J Am Soc Nephrol. 2019;30(11):2091–102. doi: 10.1681/ASN.2019030298
Open DOI Search in Google Scholar Back to article
Ng BG, Underhill HR, Palm L, Bengtson P, Rozet JM, Gerber S, et al. DPAGT1 deficiency with encephalopathy (DPAGT1-CDG): clinical and genetic description of 11 new patients. JIMD Rep. 2019;44:85–92. doi: 10.1007/8904_2018_128
Open DOI Search in Google Scholar Back to article
Pode-Shakked B, Heimer G, Vilboux T, Marek-Yagel D, Ben-Zeev B, Davids M, et al. Cerebral and portal vein thrombosis, macrocephaly and atypical absence seizures in Glycosylphosphatidyl inositol deficiency due to a PIGM promoter mutation. Mol Genet Metab. 2019;128(1–2):151–61. doi: 10.1016/j.ymg-me.2019.08.003
Open DOI Search in Google Scholar Back to article
Rush ET, Baker CV, Rizzo WB. Dolichol kinase deficiency (DOLK-CDG): two new cases and expansion of phenotype. Am J Med Genet A. 2017;173(9):2428–34. doi: 10.1002/ajmg.a.38287
Open DOI Search in Google Scholar Back to article
Li M, Cheng R, Liang J, Yan H, Zhang H, Yang L, et al. Mutations in POFUT1, encoding protein O-fucosyltransferase 1, cause generalized Dowling-Degos disease. Am J Hum Genet. 2013;92(6):895–903. doi: 10.1016/j.ajhg.2013.04.022. Epub 2013 May 16. Erratum in: Am J Hum Genet. 2013;92(6):1014.
Open DOI Search in Google Scholar Back to article
Takeuchi H, Wong D, Schneider M, Freeze HH, Takeuchi M, Berardinelli SJ, et al. Variant in human POFUT1 reduces enzymatic activity and likely causes a recessive microcephaly, global developmental delay with cardiac and vascular features. Glycobiology. 2018;28(5):276–283. doi: 10.1093/glycob/cwy014
Open DOI Search in Google Scholar Back to article
Bianchi P, Schwarz K, Högel J, Fermo E, Vercellati C, Grosse R, et al. Analysis of a cohort of 101 CDAII patients: description of 24 new molecular variants and genotype-phenotype correlations. Br J Haematol. 2016;175(4):696–704. doi: 10.1111/bjh.14271
Open DOI Search in Google Scholar Back to article
Farhan SM, Wang J, Robinson JF, Prasad AN, Rupar CA, Siu VM, et al. Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses. J Med Genet. 2015;52(10):666–75. doi: 10.1136/jmedgenet-2015-103279
Open DOI Search in Google Scholar Back to article
Jaeken J, Lefeber DJ, Matthijs G. Clinical utility gene card For: GALNT3 defective congenital disorder of glycosylation. Eur J Hum Genet. 2018;26(8):1230–3. doi: 10.1038/s41431-017-0002-5
Open DOI Search in Google Scholar Back to article
Ng BG, Sosicka P, Agadi S, Almannai M, Bacino CA, Barone R, et al. SLC35A2-CDG: functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported individuals. Hum Mutat. 2019;40(7):908–925. doi: 10.1002/humu.23731
Open DOI Search in Google Scholar Back to article
Dörre K, Olczak M, Wada Y, Sosicka P, Grüneberg M, Reunert J, et al. A new case of UDP-galactose transporter deficiency (SLC35A2-CDG): molecular basis, clinical phenotype, and therapeutic approach. J Inherit Metab Dis. 2015;38(5):931–40. doi: 10.1007/s10545-015-9828-6
Open DOI Search in Google Scholar Back to article
Winawer MR, Griffin NG, Samanamud J, Baugh EH, Rathakrishnan D, Ramalingam S, et al. Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy. Ann Neurol. 2018;83(6):1133–46. doi: 10.1002/ana.25243
Open DOI Search in Google Scholar Back to article
Ferreira CR, Xia ZJ, Clément A, Parry DA, Davids M, Taylan F, et al. A recurrent De Novo heterozygous COG4 substitution leads to Saul-Wilson syndrome, disrupted vesicular trafficking, and altered proteoglycan glycosylation. Am J Hum Genet. 2018;103(4):553– 67. doi: 10.1016/j.ajhg.2018.09.003
Open DOI Search in Google Scholar Back to article
Bui C, Huber C, Tuysuz B, Alanay Y, Bole-Feysot C, Leroy JG, et al. XYLT1 mutations in Desbuquois dysplasia type 2. Am J Hum Genet. 2014;94(3):405–14. doi: 10.1016/j.ajhg.2014.01.020
Open DOI Search in Google Scholar Back to article
LaCroix AJ, Stabley D, Sahraoui R, Adam MP, Mehaffey M, Kernan K, et al. GGC Repeat expansion and exon 1 methylation of XYLT1 is a common pathogenic variant in Baratela-Scott syndrome. Am J Hum Genet. 2019;104(1):35–44. doi: 10.1016/j. ajhg.2018.11.005
Open DOI Search in Google Scholar Back to article
Balasubramanian M, Johnson DS; DDD Study. MAN1B-CDG: Novel variants with a distinct phenotype and review of literature. Eur J Med Genet. 2019;62(2):109–114. doi: 10.1016/j.ejmg.2018.06.011
Open DOI Search in Google Scholar Back to article
Park JH, Hogrebe M, Fobker M, Brackmann R, Fiedler B, Reunert J, et al. SLC39A8 deficiency: biochemical correction and major clinical improvement by manganese therapy. Genet Med. 2018;20(2):259–68. doi: 10.1038/gim.2017.106
Open DOI Search in Google Scholar Back to article
Zaum AK, Kolokotronis K, Kress W, Goebel HH, Rost S, Seeger J. A new case expanding the mutation and phenotype spectrum of TMEM5-related alpha-dystroglycanopathy. Neuromuscul Disord. 2018;28(8):671–4. doi: 10.1016/j.nmd.2018.06.006
Open DOI Search in Google Scholar Back to article

Congenital disorders of glycosylation: A multi-genetic disease family with multiple subcellular locations

Abstract

Paradigm

My account